STBA
STBA
S&T Bancorp, Inc. (NASDAQ: STBA) is a Pennsylvania-based bank holding company headquartered in Indiana, Pennsylvania (not to be confused with the state of Indiana). Founded in 1902, S&T operates primarily in western Pennsylvania, eastern Ohio, and central New York through its S&T Bank subsidiary. With $9.9B in total assets, S&T provides commercial and retail banking services to small and medium-sized businesses and consumers. The bank has grown through acquisitions (including DNB Financial in 2020) and organic loan growth. S&T has a 13-year dividend growth streak with a 3.4% yield — among the higher yields in the community bank space. ROE of 9.25% is near industry average, reflecting the competitive Pennsylvania market.
| Business Segment | Revenue | % of Total | YoY Growth | Margin | Notes |
|---|---|---|---|---|---|
| Commercial Banking | $275M | 70% | +4.0% | — | C&I, CRE, small business lending |
| Consumer Banking | $120M | 30% | +2.0% | — | Mortgages, consumer deposits, retail |
| Blended Growth Rate | — | 100% | +3.4% | — | Weighted avg across segments |
| Metric | Value | Assessment |
|---|---|---|
| ROIC | 9.2% | 8–12% adequate |
| Revenue Trend | Growing 3yr | 3-year directional trend |
| FCF Margin Trend | Stable (±1pp) | Directional margin trajectory |
| Analyst Revisions | Neutral | Last 90 days consensus direction |
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue ($M) | $325 | $364 | $387 | $384 | $395 |
| Rev YoY Growth | — | +12.0% | +6.3% | -0.8% | +2.9% |
| Gross Margin | — | — | — | — | — |
| EBITDA ($M) | $0 | $0 | $0 | $0 | $0 |
| EBITDA Margin | — | — | — | — | — |
| Operating Income ($M) | $0 | $0 | $0 | $0 | $0 |
| Operating Margin | — | — | — | — | — |
| Net Income ($M) | $110 | $136 | $145 | $131 | $134 |
| Net Margin | 33.8% | 37.4% | 37.5% | 34.1% | 33.9% |
| EPS (diluted) | $2.81 | $3.47 | $3.74 | $3.41 | $3.49 |
| Free Cash Flow ($M) | $0 | $0 | $0 | $0 | $0 |
| Annual DPS | $1.140 | $1.230 | $1.300 | $1.340 | $1.400 |
| Total Debt ($M) | $0 | $0 | $0 | $0 | $0 |
| Scenario | Stage 1 (Yrs 1–5) | Stage 2 (Yrs 6–10) | Terminal g | Ke | Intrinsic Value | vs Price |
|---|---|---|---|---|---|---|
| 🔴 Bear | 4.0% | 3.0% | 2.0% | 9.15% | $23 | ▼45.4% |
| 📊 Base | 7.0% | 5.0% | 3.0% | 9.15% | $31 | ▼27.7% |
| 🚀 Bull | 9.5% | 6.5% | 3.5% | 9.15% | $38 | ▼10.7% |
| Period | Stage | DPS / Dist. | PV of DPS | Cumulative IV |
|---|---|---|---|---|
| Year 1 | Stage 1 | $1.498 | $1.372 | $1.37 |
| Year 2 | Stage 1 | $1.558 | $1.307 | $2.68 |
| Year 3 | Stage 1 | $1.620 | $1.246 | $3.93 |
| Year 4 | Stage 1 | $1.685 | $1.187 | $5.11 |
| Year 5 | Stage 1 | $1.752 | $1.131 | $6.24 |
| Year 6 | Stage 2 | $1.805 | $1.067 | $7.31 |
| Year 7 | Stage 2 | $1.859 | $1.007 | $8.32 |
| Year 8 | Stage 2 | $1.914 | $0.950 | $9.27 |
| Year 9 | Stage 2 | $1.972 | $0.897 | $10.16 |
| Year 10 | Stage 2 | $2.031 | $0.846 | $11.01 |
| Terminal | — | TV=$28.97 | PV(TV)=$12.07 (52% of IV) | $23.08 |
| Intrinsic Value | — | — | PV(Divs) $11.01 + PV(TV) $12.07 | $23.08 |
| Period | Stage | DPS / Dist. | PV of DPS | Cumulative IV |
|---|---|---|---|---|
| Year 1 | Stage 1 | $1.541 | $1.412 | $1.41 |
| Year 2 | Stage 1 | $1.649 | $1.384 | $2.80 |
| Year 3 | Stage 1 | $1.764 | $1.357 | $4.15 |
| Year 4 | Stage 1 | $1.888 | $1.330 | $5.48 |
| Year 5 | Stage 1 | $2.020 | $1.304 | $6.79 |
| Year 6 | Stage 2 | $2.121 | $1.254 | $8.04 |
| Year 7 | Stage 2 | $2.227 | $1.206 | $9.25 |
| Year 8 | Stage 2 | $2.338 | $1.161 | $10.41 |
| Year 9 | Stage 2 | $2.455 | $1.116 | $11.52 |
| Year 10 | Stage 2 | $2.578 | $1.074 | $12.60 |
| Terminal | — | TV=$43.17 | PV(TV)=$17.99 (59% of IV) | $30.58 |
| Intrinsic Value | — | — | PV(Divs) $12.60 + PV(TV) $17.99 | $30.58 |
| Period | Stage | DPS / Dist. | PV of DPS | Cumulative IV |
|---|---|---|---|---|
| Year 1 | Stage 1 | $1.577 | $1.445 | $1.44 |
| Year 2 | Stage 1 | $1.727 | $1.449 | $2.89 |
| Year 3 | Stage 1 | $1.891 | $1.454 | $4.35 |
| Year 4 | Stage 1 | $2.070 | $1.459 | $5.81 |
| Year 5 | Stage 1 | $2.267 | $1.463 | $7.27 |
| Year 6 | Stage 2 | $2.414 | $1.428 | $8.70 |
| Year 7 | Stage 2 | $2.571 | $1.393 | $10.09 |
| Year 8 | Stage 2 | $2.738 | $1.359 | $11.45 |
| Year 9 | Stage 2 | $2.916 | $1.326 | $12.78 |
| Year 10 | Stage 2 | $3.106 | $1.294 | $14.07 |
| Terminal | — | TV=$56.89 | PV(TV)=$23.70 (63% of IV) | $37.77 |
| Intrinsic Value | — | — | PV(Divs) $14.07 + PV(TV) $23.70 | $37.77 |
| Ke \ gT | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.1% | $37 | $40 | $43 | $47 | $51 |
| 7.6% | $34 | $36 | $38 | $41 | $45 |
| 8.2% | $31 | $32 | $34 | $36 | $39 |
| 8.6% | $29 | $30 | $32 | $34 | $36 |
| 9.1% | $27 | $28 | $29 | $31 | $33 |
| 9.7% | $25 | $26 | $27 | $28 | $29 |
| 10.1% | $24 | $24 | $25 | $26 | $27 |
| 10.6% | $22 | $23 | $24 | $25 | $25 |
| 11.2% | $21 | $21 | $22 | $23 | $23 |
Green = >10% above current price. Red = >10% below. Gold = within ±10%.
Log-linear trend fitted to full price history. ±1.5σ bands. Green shaded zone = bottom 25% of historical range — historically attractive entry.
| Company | P/E | P/B | Div Yield | ROE | Note |
|---|---|---|---|---|---|
| STBA (current) | 12.1x | 1.11x | 3.4% | 9.3% | 13-yr div growth; PA regional |
| 1st Source (SRCE) | 10.9x | 1.35x | 2.3% | 13.0% | IN/MI; superior ROE; 39-yr streak |
| Univest Financial | 10.2x | 1.05x | 3.5% | 10.0% | PA peer; similar profile |
| Mid Penn Bancorp | 9.8x | 0.90x | 2.4% | 9.0% | Central PA; smaller scale |
| WSFS Financial | 11.5x | 1.20x | 1.8% | 11.0% | Delaware Valley; larger scale |
| Metric | Value |
|---|---|
| Annual DPS | $1.440 |
| Current Yield | 3.41% |
| Consecutive Growth Years | 13 |
| 1-yr DPS CAGR | +4.5% |
| 3-yr DPS CAGR | +4.8% |
| 5-yr DPS CAGR | +5.2% |
| 10-yr DPS CAGR | +4.5% |
| Payout Ratio (DPS/EPS) | 40.1% |
| FCF Payout Ratio | 40.0% |
| Sustainability Verdict | Safe |
| Year | Low / Actual | Avg | High | # Analysts | Type |
|---|---|---|---|---|---|
| 2021 | $2.81 | — | — | — | Actual |
| 2022 | $3.47 | — | — | — | Actual |
| 2023 | $3.74 | — | — | — | Actual |
| 2024 | $3.41 | — | — | — | Actual |
| 2025 | $3.49 | — | — | — | Actual |
| 2026 | $3.49 | $3.69 | $3.87 | 9 | Estimate |
| 2027 | $3.67 | $3.85 | $4.03 | 9 | Estimate |
| Year | Low / Actual | Avg | High | # Analysts | Type |
|---|---|---|---|---|---|
| 2021 | $0.3B | — | — | — | Actual |
| 2022 | $0.4B | — | — | — | Actual |
| 2023 | $0.4B | — | — | — | Actual |
| 2024 | $0.4B | — | — | — | Actual |
| 2025 | $0.4B | — | — | — | Actual |
| 2026 | $0.4B | $0.4B | $0.5B | 9 | Estimate |
| 2027 | $0.4B | $0.5B | $0.5B | 9 | Estimate |
| Analyst | Firm | Rating | PT | Upside |
|---|---|---|---|---|
| Jake Civiello | DA Davidson | Hold | $47 | +11.2% |
| Daniel Cardenas | Janney Montgomery Scott | Strong Buy | $46 | +8.8% |
| Michael Perito | KBW | Hold | $42 | -0.7% |
| Justin Crowley | Piper Sandler | Hold | $40 | -5.4% |
P/B Justified Multiple Analysis:
P/B = (ROE - g) / (Ke - g) where ROE=9.25%, Ke=9.15%, g=2.5% terminal
Justified P/B = (0.0925 - 0.025) / (0.0915 - 0.025) = 0.0675 / 0.0665 = 1.02x
Current P/B = $42.28 / $38.03 = 1.11x
→ STBA trades at a 9% premium to justified P/B. At current ROE, stock is fairly valued to slightly expensive.
If ROE improves to 11% (bull case): Justified P/B = (0.11 - 0.025) / (0.0915 - 0.025) = 1.28x → fair value ~$48.
Bull case: Pennsylvania economy strengthens; NIM expands from loan growth. ROE improves to 11% justifying P/B re-rating to 1.3x. Dividend grows 6–7%/yr. Target: $47–$50.
Bear case: CRE concentration (~30% of loans) creates credit risk if office/retail stress spreads. ROE could compress to 8%, justifying only 0.83x P/B → fair value $32. Higher beta (0.89) means more volatility than SRCE in downturns.
Base case: ROE stays ~9%, book value grows 5%/yr, P/B holds at 1.1x. Fair value ~$42–$44. Dividend yield of 3.4% + 4% dividend growth = 7–8% total return.
Compensation: Equity-based compensation present
Company profile page for S&T Bancorp Inc including stock price, company news, executives, board members, and contact information
By providing your email address below, you are providing consent to S&T Bancorp, Inc.
(S&T) (NASDAQ: STBA), the holding company for S&T Bank, today announced that Christine J. Toretti, chair of the board of directors of both S&T Bancorp, Inc. and S&T Bank since 2018, and a director since 1984
You’re viewing 5 of 6 acquisitions. Get the full list » ... Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements
S&T Bancorp’s 2025 annual report shows $9.9B in assets, $8.1B in loans and strong capital ratios well above well‑capitalized levels, alongside detailed regulatory, risk and human capital disclosures.
- recommend
Employees also rated S&T Bancorp 3.8 out of 5 for work life balance, 4.1 for culture and values and 4.0 for career opportunities. What are the pros and cons of working at S&T Bancorp?
not recognized for the extra work you take on after they release staff so they can increase their own wealth. CEO's you can't spend it when your dead.
Not a bad place to build a career, ighly performance driven culture in sales/business development roles On-boarding: below average Culture: average Pay/comp: average Benefits: average Management vision: average
| Tier | Price | Action |
|---|---|---|
| Tier 1 — Starter | ≤$28 | Begin position |
| Tier 2 — Add | ≤$27 | Add on weakness |
| Tier 3 — Full | ≤$24 | Full allocation |
| Sell Alert | ≥$32 | Above fair value — consider trimming |
Hold at current levels. At $42.28, STBA is fairly valued — P/B of 1.11x aligns with 9.25% ROE. The 3.4% dividend yield is attractive but growth is modest. Accumulate below $38; full position at $35. STBA is a yield play, not a growth play. Thesis breaks if CRE credit losses spike or ROE falls below 8%. At $48+, reduce to underweight.
| Assumption | Rationale / Notes |
|---|---|
| Model Choice | P/B Justified Multiple primary; DDM cross-check. Both methods converge on ~$40–$45 fair value. |
| ROE Input | ROE 9.25% (Finnhub TTM). This is near cost of equity (9.15%), meaning STBA earns near its required return — P/B ~1.0x is justified. |
| Ke for DDM | Ke = 4.25% (Rf) + 0.89 (beta) × 5.5% (ERP) = 9.15%. Higher beta than SRCE reflects more cyclicality. |
| Justified P/B | At ROE=9.25%, Ke=9.15%, g=2.5%: Justified P/B = 1.02x. Current P/B = 1.11x. Slight premium to fair value. |
| DDM Cross-Check | DDM with DPS $1.44, g1=5%, gT=2.5%, Ke=9.15% yields IV ~$38–$42. Consistent with current price. |
| CRE Risk | CRE represents ~30% of loan book. Pennsylvania office/retail markets are stable but warrant monitoring. Not a red flag but a watchlist item. |